Treatment-naïve HPV+ head and neck cancers display a T-cell-inflamed phenotype distinct from their HPV- counterparts that has implications for immunotherapy-Reference-Cited by-同舟云学术

Treatment-naïve HPV+ head and neck cancers display a T-cell-inflamed phenotype distinct from their HPV- counterparts that has implications for immunotherapy

Published:2018-07-30 Issue:10 Volume:7 Page:e1498439
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Gameiro Steven F.¹,Ghasemi Farhad²,Barrett John W.²,Koropatnick James¹³⁴⁵⁶,Nichols Anthony C.²³⁶,Mymryk Joe S.¹²³⁶,Maleki Vareki Saman³⁶

Affiliation:

1. Department of Microbiology and Immunology, The University of Western Ontario, London, ON, Canada

2. Department of Otolaryngology, Head & Neck Surgery, The University of Western Ontario, London, ON, Canada

3. Department of Oncology, The University of Western Ontario, London, ON, Canada

4. Department of Pathology, The University of Western Ontario, London, ON, Canada

5. Department of Physiology and Pharmacology, The University of Western Ontario, London, ON, Canada

6. London Regional Cancer Program, Lawson Health Research Institute, London, ON, Canada

Funder

Canadian Institutes of Health Research

Cancer Research and Technology Transfer

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2018.1498439

Reference49 articles.

1. The blockade of immune checkpoints in cancer immunotherapy

2. Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy

3. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

4. Ten Years of Progress in Head and Neck Cancers

Cited by 124 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deciphering the interplay of HPV infection, MHC-II expression, and CXCL13+ CD4+ T cell activation in oropharyngeal cancer: implications for immunotherapy;Cancer Immunology, Immunotherapy;2024-08-06

2. Clinical, genomic and immune microenvironmental determinants of nivolumab response in head and neck squamous cell carcinoma;Frontiers in Immunology;2024-07-29

3. Type I conventional dendritic cells and CD8+ T cells predict favorable clinical outcome of head and neck squamous cell carcinoma patients;Frontiers in Immunology;2024-06-13

4. Investigating immune and non‐immune cellular profiles in recurrent respiratory papillomatosis by multi‐omics;Clinical and Translational Medicine;2024-03

5. Depletion of effector regulatory T cells drives major response to induction dual immune checkpoint blockade;2024-01-04